Serum Uric Acid Level in Unipolar and Bipolar Depression

Authors

  • Gülçin Elboğa Gaziantep University Faculty of Medicine http://orcid.org/0000-0003-3903-1835
  • Muhammet Berkay Özyürek Balıkesir University
  • Zeynel Abidin Sayıner Gaziantep University
  • Şengül Kocamer Şahin Gaziantep University Faculty of Medicine http://orcid.org/0000-0002-5371-3907
  • Abdurrahman Altındağ Gaziantep University Faculty of Medicine

DOI:

https://doi.org/10.31964/mltj.v5i1.202

Keywords:

bipolar disorder, major depressive disorder, uric acid, purinergic dysfunction, inflammation

Abstract

The purinergic system plays a role in the regulation of mood, motor activity, cognitive function, sleep, and behavior. Purinergic mechanisms can also play a role in various neuropsychiatric diseases. The objective of this study is to assess whether uric acid levels in patients with unipolar and bipolar depression are different in comparison to healthy controls and to determine the clinical parameters that can be associated with the uric acid level. This retrospective study consisted of 31 patients with major depressive disorder and 31 patients with bipolar disorder depressive episode and 31 healthy control subjects. The mean serum uric acid levels were found as follows: major depression patient group 4.56 (± 1.53) mg/dL, bipolar depression patient group 5.38 (± 1.43) mg/dL and control group 4.86 (± 1.56) mg/dL. There was no significant difference between patients and the control groups in terms of serum uric acid levels (P=0.075). Serum uric acid levels do not differ significantly in bipolar and unipolar depression. Also, there was no difference between patients and control. Therefore, studying the uric acid metabolism in major depression and bipolar disorder depressive episode according to the symptom severity with larger sample groups is suggested.

Downloads

Additional Files

Published

2019-06-17

How to Cite

Elboğa, G., Özyürek, M. B., Sayıner, Z. A., Şahin, Şengül K., & Altındağ, A. (2019). Serum Uric Acid Level in Unipolar and Bipolar Depression. Medical Laboratory Technology Journal, 5(1), 49–53. https://doi.org/10.31964/mltj.v5i1.202

Issue

Vol. 5 No. 1 (2019): June

Section

Articles

License

Publishing your paper with Medical Laboratory Technology Journal (MLTJ) means that the author or authors retain the copyright in the paper. MLTJ granted an author(s) rights to put the paper onto a website, distribute it to colleagues, give it to students, use it in your thesis etc, even commercially. The author(s) can reuse the figures and tables and other information contained in their paper published by MLTJ in future papers or work without having to ask anyone for permission, provided that the figures, tables or other information that is included in the new paper or work properly references the published paper as the source of the figures, tables or other information, and the new paper or work is not direct at private monetary gain or commercial advantage.

MLTJ journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. This journal is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets others remix, transform, and build upon the material for any purpose, even commercially. MLTJ journal Open Access articles are distributed under this Creative Commons Attribution-ShareAlike 4.0 International License (CC BY-SA). Articles can be read and shared for All purposes under the following conditions:


BY: You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
SA: If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.